Description: Mozobil, an FDA-approved medication, is used to mobilize stem cells in patients with NHL or MM planning to undergo stem cell transplant. See Important Safety Information.
Mozobil is approved by the FDA to be used in combination with another agent granulocyte‑colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients living with non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM) .
Learn how Mozobil could help
Our passion is to facilitate access and provide support to patients. Explore available resources, including the Sanofi Patient Connection Support Program.
Hemophilia B coagulation Factor IX concentrate for adults and children | ALPROLIX® Professional
ALTUVIIIO® Homepage | Sanofi | for US HCPs
Beyfortus® (nirsevimab-alip) for RSV | For US HCPs | Sanofi Campus US
It’s time to look at the bigger picture in hemophilia B | HCP Site
Exploring Our Prescription Product Information | Sanofi USA